RT Journal Article
SR Electronic
T1 British Gynaecological Cancer Society recommendations for women with gynecological cancer who received non-standard care during the COVID-19 pandemic
JF International Journal of Gynecologic Cancer
JO Int J Gynecol Cancer
FD BMJ Publishing Group Ltd
SP 9
OP 14
DO 10.1136/ijgc-2021-002942
VO 32
IS 1
A1 Alexandra Taylor
A1 Sudha S Sundar
A1 Rebecca Bowen
A1 Rick Clayton
A1 Sarah Coleridge
A1 Christina Fotopoulou
A1 Sadaf Ghaem-Maghami
A1 Jonathan Ledermann
A1 Ranjit Manchanda
A1 Hilary Maxwell
A1 Agnieszka Michael
A1 Tracie Miles
A1 Shibani Nicum
A1 Andrew Nordin
A1 Bruce Ramsay
A1 Stuart Rundle
A1 Sarah Williams
A1 Nicholas J Wood
A1 Dennis Yiannakis
A1 Jo Morrison
YR 2022
UL http://ijgc.bmj.com/content/32/1/9.abstract
AB During the COVID-19 pandemic, pressures on clinical services required adaptation to how care was prioritised and delivered for women with gynecological cancer. This document discusses potential ‘salvage’ measures when treatment has deviated from the usual standard of care. The British Gynaecological Cancer Society convened a multidisciplinary working group to develop recommendations for the onward management and follow-up of women with gynecological cancer who have been impacted by a change in treatment during the pandemic. These recommendations are presented for each tumor type and for healthcare systems, and the impact on gynecological services are discussed. It will be important that patient concerns about the impact of COVID-19 on their cancer pathway are acknowledged and addressed for their ongoing care.